Journals Articles Conferences News About CLP
Submit a paper Email Alert
Search
Search
Articles
Journals
News
Advanced Search
Top Searches
2D MaterialsTransformation opticsQuantum PhotonicsSmall lasersSemiconductor UV PhotonicsSupersymmetric microring laser arrays

World Clinical Drugs, Volume. 46, Issue 7, 675(2025)

The effect of trastuzumab combined with TP regimen on PAI-1, HER2 receptors and lymphocyte subsets in breast cancer patients

FANG Xun1, LIU Beibei1, ZHU Qilong1, and JIAO Hao2
Author Affiliations
  • 1Department of Pharmacy, Yingshang County People's Hospital, Yingshang 236200, Anhui Province, China
  • 2Department of Pharmacy, the First Affiliated Hospital of Wannan Medical College/Yijishan Hospital, Wuhu 241001, Anhui Province, China
    • show less
    AbstractGet PDF(in Chinese)
    Figures&Tables (0)
    Equations (0)
    References (3)
    Tools
    Paper Information
    Topics
    References(3)

    [3] [3] HUANG X, SONG C, ZHANG J,et al. Circular RNAs in breast cancer diagnosis, treatment and prognosis[J]. Oncol Res, 2023, 32(2): 241-249.

    [12] [12] ZANNETTI A. Breast cancer: from pathophysiology to novel therapeutic approaches 2.0[J]. Int J Mol Sci, 2023, 24(3):2542.

    [15] [15] JAGSI R, MASON G, OVERMOYER BA,et al. Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research [J]. Breast Cancer Res Treat, 2022, 192(2): 235-243.

    Tools

    Get Citation

    Copy Citation Text

    FANG Xun, LIU Beibei, ZHU Qilong, JIAO Hao. The effect of trastuzumab combined with TP regimen on PAI-1, HER2 receptors and lymphocyte subsets in breast cancer patients[J]. World Clinical Drugs, 2025, 46(7): 675

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Set citation alerts for article
    Save article for my favorites
    Paper Information

    Category:

    Received: Mar. 2, 2025

    Accepted: Aug. 26, 2025

    Published Online: Aug. 26, 2025

    The Author Email:

    DOI:10.13683/j.wph.2025.07.008

    Topics